Paper · 39367249
Atomic force microscopy reveals morphological and mechanical properties of schistosoma mansoni tegument.
Dantas AMC and 7 others. Sci Rep, 2024. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Atomic force microscopy reveals morphological and mechanical properties of schistosoma mansoni tegument. Papers, record 39367249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39367249
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atomic force microscopy reveals morphological and mechanical properties of schistosoma mansoni tegument.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Schistosoma mansoni | Major topic |
| Microscopy, Atomic Force | Major topic |
| Animals | |
| Female | |
| Elastic Modulus | |
| Biomechanical Phenomena |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 131692/2021-6 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed | ||
| 305200/2022-4 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed | ||
| 001 | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | PubMed | ||
| 2023/08418-6 | Fundação de Amparo à Pesquisa do Estado de São Paulo | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,986,763 | Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review. | Infect Dis Poverty | 2018 | https://conductscience.org/library/papers/29986763 | PubMed |
| 2 | 33,482,425 | Combination of synthetic anthelmintics and monoterpenes: Assessment of efficacy, and ultrastructural and biophysical properties of Haemonchus contortus using atomic force microscopy. | Vet Parasitol | 2021 | https://conductscience.org/library/papers/33482425 | PubMed |
| 3 | 6,854,474 | Schistosoma mansoni: evaluation of selected preparative procedures for transmission and scanning electron microscopy. | J Parasitol | 1983 | https://conductscience.org/library/papers/6854474 | PubMed |
| 4 | 31,527,034 | Promethazine exhibits antiparasitic properties in vitro and reduces worm burden, egg production, hepato-, and splenomegaly in a schistosomiasis animal model. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31527034 | PubMed |
| 5 | 32,819,092 | Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis. | ACS Infect Dis | 2021 | https://conductscience.org/library/papers/32819092 | PubMed |
| 6 | 33,896,196 | New evidence for tamoxifen as an antischistosomal agent: in vitro, in vivo and target fishing studies. | Future Med Chem | 2021 | https://conductscience.org/library/papers/33896196 | PubMed |
| 7 | 37,409,934 | The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37409934 | PubMed |
| 8 | 4,978,052 | Experimental chemotherapy of Schistosomiasis mansoni. | Adv Parasitol | 1968 | https://conductscience.org/library/papers/4978052 | PubMed |
| 9 | 16,545,817 | Functions of the tegument of schistosomes: clues from the proteome and lipidome. | Int J Parasitol | 2006 | https://conductscience.org/library/papers/16545817 | PubMed |
| 10 | 22,115,064 | Characterization of cell elasticity correlated with cell morphology by atomic force microscope. | J Biomech | 2012 | https://conductscience.org/library/papers/22115064 | PubMed |
1 to 10 of 32
See all 32 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41,530,388 | Cancer in disguise: a parasite within. | EMBO J | 2026 | https://conductscience.org/library/papers/41530388 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39367249
GET https://conductscience.org/api/papers/v1/39367249/references?page=2